3.8 Article

A Mobile Phone App for the Prevention of Type 2 Diabetes in Malaysian Women With Gestational Diabetes Mellitus: Protocol for a Feasibility Randomized Controlled Trial

期刊

JMIR RESEARCH PROTOCOLS
卷 11, 期 9, 页码 -

出版社

JMIR PUBLICATIONS, INC
DOI: 10.2196/37288

关键词

gestational diabetes mellitus; diabetes prevention; randomized controlled trial; mobile app

资金

  1. Medical Research Council [MR/T018240/1]
  2. Malaysia Partnerships and Alliances in Research (MYPAIR) Grant UK-Malaysia: Joint Partnership Call on Non-Communicable Diseases (Malaysia) [JPT.S(BPKl)2000/011/06/05(27)]
  3. National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London
  4. NIHR Applied Research Collaboration South London at King's College Hospital NHS Foundation Trust

向作者/读者索取更多资源

This study aims to test the feasibility of a digital intervention for type 2 diabetes (T2D) prevention among women with a history of gestational diabetes mellitus (GDM) in Malaysia. The intervention includes a smartphone app and group support, providing tailored information and support to encourage weight loss through adapted dietary intake and physical activity. This will be the first study in Malaysia focusing on T2D prevention among women with GDM using a digital intervention.
Background: Over 50% of women with a history of gestational diabetes mellitus (GDM) will develop type 2 diabetes (T2D) in later life. Asian women experience a disproportionate risk of both GDM and T2D compared to women from other ethnic backgrounds. Lifestyle interventions and behavior change can delay or even prevent the onset of T2D. We have developed a digitalized diabetes prevention intervention for the prevention of T2D in Malaysian women with GDM. Objective: The protocol describes a randomized controlled trial (RCT) to test the feasibility of undertaking a definitive trial of a diabetes prevention intervention, including a smartphone app and group support. Secondary aims are to summarize anthropometric, biomedical, psychological, and lifestyle outcomes overall and by allocation group, and to undertake a process evaluation. Methods: This is a two-arm parallel feasibility RCT. A total of 60 Malaysian women with GDM will be randomized in the antenatal period to receive the intervention or standard care until 12 months post partum. The intervention is a diabetes prevention intervention delivered via a smartphone app developed based on the Information-Motivation-Behavioral Skills model of behavior change and group support using motivational interviewing. The intervention provides women with tailored information and support to encourage weight loss through adapted dietary intake and physical activity. Women in the control arm will receive standard care. The Malaysian Ministry of Health's Medical Research and Ethics Committee has approved the trial (NMRR-21-1667-60212). Results: Recruitment and enrollment began in February 2022. Future outcomes will be published in peer-reviewed health-related research journals and presented at national, regional, or state professional meetings and conferences. This publication is based on protocol version 2, January 19, 2022. Conclusions: To our knowledge, this will be the first study in Malaysia that aims to determine the feasibility of a digital intervention in T2D prevention among women with GDM. Findings from this feasibility study will inform the design of a full-scale RCT in the future. Trial Registration: ClinicalTrials.gov NCT05204706; https://clinicaltrials.gov/ct2/show/NCT05204706

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据